An internationally recognized testing institution, assisting enterprises in achieving technological advancement.
ZHONGXI Testing has obtained inspection qualification certifications from multiple countries and regions worldwide. We possess a senior testing team and advanced testing methods, providing independent, impartial, and professional third-party verification services for global carbon projects.
Certified by multiple international standards such as CNAS, VCS, and GS, with reports universally applicable worldwide.
Covering 140+ countries and regions, it supports on-site detection and remote verification in multiple languages.
Adopt standard experimental methods to ensure accurate and reliable data.
The comprehensive characterisation of microbial community structure, composition, and functional potential through microbiome diversity analysis has become indispensable across a vast range of fields – from human health and nutrition, environmental microbiology, and agricultural soil science to bioprocess engineering and industrial biotechnology. Understanding the richness, evenness, and phylogenetic composition of a microbial community is not merely an academic pursuit; it provides critical insights into ecosystem function, host‑microbe interactions, disease aetiology, and the impact of interventions (e.g., probiotics, antibiotics, dietary changes, or environmental pollutants). However, the depth and reliability of a microbiome diversity study are not guaranteed by simply running a standard 16S rRNA amplicon protocol. The successful characterisation depends critically on experimental design, sample collection and preservation, DNA extraction efficiency, choice of amplification primers and sequencing platform, rigorous bioinformatics processing, and, most importantly, the statistical interpretation of diversity indices and multivariate ordinations. A poorly designed workflow can lead to batch effects, amplification biases, overestimation of rare taxa, and misinterpretation of beta‑diversity patterns. Regulatory and research standards (e.g., the Minimum Information about a Marker Gene Sequence (MIMARKS) and the Environmental Microbiology Minimum Information (EMMI) guidelines) demand transparent and reproducible workflows. Our ISO/IEC 17025‑accredited and GMP‑compliant laboratory offers a fully integrated microbiome diversity analysis platform, encompassing the entire spectrum from sample collection and DNA extraction to high‑throughput sequencing (Illumina, Nanopore, or PacBio) and comprehensive bioinformatics analysis – including alpha diversity (Shannon, Simpson, Chao1, observed OTUs/ASVs), beta diversity (Bray‑Curtis, Jaccard, UniFrac), ordination (PCA, PCoA, NMDS), differential abundance testing (DESeq2, ANCOM‑BC), and functional prediction (PICRUSt2, METAGENassist, or metabolic pathway reconstruction). We deliver quantitative, traceable data, detailed graphical outputs, and expert biological interpretation, enabling you to unravel the complex ecological dynamics of your microbial communities and to derive actionable insights for your research, product development, or quality control programmes.

Microbiome diversity analysis serves multiple critical objectives: (a) to characterise the core and transient microbiota of a given niche (e.g., gut, skin, rhizosphere, or bioreactor); (b) to compare the structural and functional differences between healthy and diseased states, or between treatment and control groups; (c) to monitor the dynamics of community assembly and succession over time or under stress; (d) to identify specific taxa or functional genes that are associated with a particular phenotype; and (e) to assess the impact of industrial processes (e.g., fermentation, wastewater treatment, or bioprocess monitoring) on microbial communities. The choice of method – whether targeted amplicon sequencing (16S rRNA, ITS, or 18S rRNA), whole‑metagenome shotgun sequencing, or metatranscriptomics – must be aligned with the research question, the expected taxonomic depth, and the need for functional inference. The selection of appropriate alpha and beta diversity metrics, the handling of sequence variants (OTUs vs. ASVs), and the use of appropriate statistical tests (permutational multivariate ANOVA, ANOSIM, or Mantel tests) are essential to avoid false discoveries. Our service begins with a comprehensive consultation to define the optimal experimental strategy – including sampling design, replication, sequencing depth, and the most relevant bioinformatics pipelines – to ensure that your study is both scientifically robust and compliant with best‑practice standards.
We maintain a complete suite of validated microbiome analysis workflows, all performed in a dedicated molecular laboratory with strict contamination controls (including negative extraction and PCR controls) and with certified reference materials for sequencing quality control. Our portfolio includes:
2.1 Nucleic Acid Extraction and Quality Control – The Foundation of Reliable Diversity Data
We use optimised extraction protocols (bead‑beating, enzymatic lysis, or spin‑column methods) to isolate high‑quality DNA or RNA from a wide range of sample types: faeces, saliva, skin swabs, soil, water, biofilms, and clinical specimens. We include an internal spike‑in control to assess extraction efficiency and the presence of PCR inhibitors. We quantify the extracted nucleic acids using fluorometric methods (Qubit) and assess integrity via agarose gel or capillary electrophoresis (e.g., BioAnalyzer or Fragment Analyzer). We ensure that the DNA is of sufficient purity (A260/280 > 1.8) and that the starting material is adequate for the chosen sequencing approach.
2.2 Amplicon Library Preparation and Sequencing – 16S rRNA, ITS, and Custom Panels
We prepare amplicon libraries targeting the variable regions of the 16S rRNA gene (e.g., V3‑V4, V4, or V1‑V3) for bacteria and archaea, the ITS region for fungi, or the 18S rRNA gene for micro‑eukaryotes. We use dual‑indexed primers to allow multiplexing, and we incorporate mock community standards (e.g., ZymoBIOMICS Microbial Community Standards) to validate the sequence processing pipeline and to correct for amplification biases. We sequence on Illumina MiSeq or NovaSeq platforms (producing 2×250 or 2×300 paired‑end reads) to achieve sufficient read depth (typically ≥ 50,000 reads per sample). For full‑length 16S rRNA or whole‑metagenome applications, we also use Oxford Nanopore or PacBio sequencing.
2.3 Whole‑Metagenome Shotgun Sequencing – Beyond Taxonomy to Functional Potential
For in‑depth functional and taxonomic resolution, we perform shotgun metagenomic sequencing (targeting > 10 million reads per sample). This approach enables the species‑level taxonomic assignment (using MetaPhlAn, Kraken2, or mOTUs) and the reconstruction of metabolic pathways (using HUMAnN3, MEGAN, or KEGG and EggNOG databases). We provide both the taxonomic profile and the functional repertoire of the community, allowing you to link community composition to ecosystem function.
2.4 Metatranscriptomics – Active Community Function Assessment
We perform metatranscriptomics (RNA‑seq of the microbial community) to assess the actively expressed genes and pathways, providing a dynamic picture of the functional state of the community in response to environmental changes or interventions. This includes ribosomal RNA depletion, cDNA synthesis, and Illumina sequencing, followed by assembly and differential expression analysis.
2.5 Bioinformatics Processing – From Raw Reads to Biological Insights
Our validated bioinformatics pipeline includes: (i) quality filtering and trimming (using Trimmomatic or cutadapt); (ii) denoising and ASV (amplicon sequence variant) inference (using DADA2, Deblur, or UNOISE3); (iii) taxonomic assignment against the SILVA, GreenGenes, or RDP databases (using the naive Bayesian classifier or BLAST); (iv) phylogenetic tree construction (using FastTree or RAxML); (v) alpha diversity (observed ASVs, Shannon, Simpson, Chao1, ACE, and Faith’s phylogenetic diversity); (vi) beta diversity (Bray‑Curtis, Jaccard, weighted and unweighted UniFrac); and (vii) ordination and clustering (PCA, PCoA, NMDS, t‑SNE, and UMAP). We also perform PERMANOVA, ANOSIM, and PERMDISP to test for differences between groups, and we adjust for multiple comparisons.
2.6 Functional Prediction – PICRUSt2, METAGENassist, and Custom Models
We use PICRUSt2 (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States) to predict the functional gene content of your microbial communities based on 16S rRNA ASVs, allowing you to estimate the abundance of KEGG Orthologs (KOs) and metabolic pathways. For shotgun metagenomics, we directly quantify functional gene abundance using HUMAnN3 and the UniRef90 database.
2.7 Statistical Analysis and Visualisation – Translating Numbers into Conclusions
We perform differential abundance analysis using DESeq2, ANCOM‑BC, or edgeR to identify taxa that are significantly enriched or depleted between conditions, with appropriate correction for false discovery rate (FDR). We generate publication‑ready figures: rarefaction curves, bar plots (for relative abundance), heatmaps, PCoA plots with ellipses, and network diagrams (for co‑occurrence). We also provide LEfSe (Linear Discriminant Analysis Effect Size) to identify the most discriminant taxa and functional pathways.
For clients requiring deeper insights or a high‑level integration of different data types, we offer a suite of customised, research‑grade services that go beyond standard diversity analysis:
3.1 Multi‑Omics Integration – Combining Metagenomics, Metatranscriptomics, and Metabolomics
We provide integrated analysis of multi‑omics data, correlating microbial composition and function with metabolites (from LC‑MS or NMR metabolomics) or with host gene expression (from RNA‑seq). We use canonical correlation analysis (CCA), DIABLO, and sparse partial least squares (sPLS) models to identify the key microbial drivers of the metabolic or host response.
3.2 Machine Learning and Predictive Modelling – Classification and Biomarker Discovery
We employ machine learning algorithms (e.g., Random Forest, Support Vector Machines, Neural Networks) to build predictive models that can classify samples into categories (e.g., healthy vs. diseased) based on their microbial profiles. We provide feature importance scores and a comprehensive evaluation of model performance (ROC‑AUC, cross‑validation). This service is particularly valuable for developing diagnostic or prognostic biomarkers.
3.3 Custom Amplicon and Probe Set Design – For Specific Taxa or Functional Genes
We can design custom primer pairs or probe sets to target specific bacterial groups (e.g., Lactobacillus, Bifidobacterium, or E. coli) or functional genes (e.g., antibiotic resistance genes, virulence factors, or metabolic markers) and provide a targeted and cost‑effective analysis.
3.4 Longitudinal and Time‑Series Analysis – Tracking Community Dynamics
We perform time‑series analysis using dynamic community models and change‑point detection to identify significant shifts in community structure over time. We provide data visualisation using trellis plots and transition matrices to illustrate community state changes.
3.5 Network and Co‑occurrence Analysis – Unravelling Microbial Interactions
We construct co‑occurrence and co‑exclusion networks using SparCC, SPIEC‑EASI, or MINE, and we calculate network metrics (centrality, modularity, and clustering) to infer potential ecological interactions between taxa. This is essential for understanding the stability and resilience of the community.
3.6 Bioinformatic Workflow Customisation – For Non‑Standard Data Types or DBs
We can adapt our pipelines to non‑standard amplicons, low‑biomass samples, or specific reference databases (e.g., custom genomic datasets) to meet your specific research needs.
All analyses are conducted under a strict quality management system that includes the use of certified reference materials, routine negative controls, and participation in proficiency testing schemes (e.g., the International Human Microbiome Standards (IHMS) pilot studies). Our reports provide:
Our reports are authored by senior bioinformaticians and microbial ecologists who provide not just raw data, but contextual insights that help you understand the ecological and clinical significance of your results.
Turnaround times: 2‑3 weeks for 16S rRNA amplicon analysis, 3‑4 weeks for shotgun metagenomics, and 4‑5 weeks for integrated multi‑omics studies. Express services are available for urgent projects.
We are one of the few laboratories that hold ISO/IEC 17025 accreditation for microbiome testing, covering both the wet‑lab and computational workflows. Our integrated infrastructure combines a state‑of‑the‑art molecular biology facility, multiple sequencing platforms, and a powerful bioinformatics cluster – enabling cross‑verification of results and a complete understanding of the microbial community. Our team comprises PhD‑level microbiologists, bioinformaticians, and biostatisticians with extensive experience in experimental design, method validation, and the analysis of large‑scale microbiome datasets. We have a proven track record of supporting projects in clinical research, environmental monitoring, and industrial biotechnology.
We offer unparalleled flexibility: we accept a wide range of sample types – from human and animal specimens to soil, water, air, and food matrices – and we provide customised sampling kits with stabilising buffers and clear instructions. Our secure online portal enables real‑time tracking, access to raw sequencing data, and downloadable reports.
Our modular pricing ensures cost‑effectiveness: you select the level of analysis – from a simple 16S profiling to a comprehensive multi‑omics integration – with discounts for routine monitoring programmes and bulk submissions. We also provide training, method transfer, and technical consultancy to help you build or strengthen your internal microbiome analysis capabilities.
With a proven history of serving over 90 clients in the pharmaceutical, biotechnology, environmental, and nutrition sectors, we have enabled our partners to uncover novel microbial signatures, validate hypotheses, and accelerate product development. We invite you to leverage our expertise for your microbiome diversity analysis needs.
Contact our technical experts today to discuss your research questions, sample types, and analytical requirements. We will design a tailored testing plan and provide a detailed proposal within one business day.
Beijing ZKGX Institute of Science and Technology , combining applied research with technological transformation. It has evolved into a comprehensive research institute characterized primarily by a "task-driven disciplines" approach. Approved by relevant authorities, it currently operates as a third-party analytical testing technical service provider. Its affiliated laboratory facilities hold certifications including CMA and CNAS, possess an Experimental Animal Use License, and have achieved triple certification for ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.